Paramedic Papers

Home Cardiac (non-arrest) PANDA trial: noradrenaline vs adrenaline in shock

Cardiac (non-arrest)

PANDA trial: noradrenaline vs adrenaline in shock

Design and rationale of a multicenter paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock—The PANDA trial
American Heart Journal · Added 23 May 2026

This multicenter RCT protocol tests whether noradrenaline improves outcomes compared with adrenaline for paramedic management of cardiogenic shock, with the PANDA trial aiming to settle the debate on optimal vasopressor choice in the prehospital setting.

Study type
RCT
Design
Protocol for prehospital multicentre open-label RCT
Participants
Planned 1,155 patients with suspected cardiogenic shock (450 recruited to date)
Main finding
Trial randomises paramedic-administered noradrenaline vs adrenaline to target SBP 100 mmHg; primary outcome 28-day all-cause mortality; results not yet available
Caveat
Protocol only — no outcome data yet
Bottom line
Context only

Learning goal

Weigh the evidence for noradrenaline versus adrenaline when supporting blood pressure in prehospital cardiogenic shock.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Cardiac (non-arrest)